We are live on ! Find out more
NITE

Nightstar Therapeutics plc American Depositary Shares
NITE

Delisted

NITE was delisted on the 6th of June, 2019.

Back to rankings

0 hedge funds and large institutions have $0 invested in Nightstar Therapeutics plc American Depositary Shares in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 53 → 0 (-53)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $279M → $0 (-$279M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 53

Holders
–
Holders Change
-53
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
53
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
TAM
TFG Asset Management
Cayman Islands
-$40.6M
2
MF
Magnetar Financial
Illinois
-$32.2M
3
NMC
NEA Management Company
Maryland
-$30.8M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$18.5M
5
GF
Gabelli Funds
New York
-$18M
Name Holding Trade Value Shares
Change 		Change in
Stake
HA
26
Havens Advisors
New York
– -$1.45M -57,000 Closed
EGPO
27
EnTrust Global Partners Offshore
New York
– -$1.41M -55,700 Closed
GI
28
GAMCO Investors
Connecticut
– -$1.2M -47,403 Closed
UBS Group
29
UBS Group
Switzerland
– -$1.11M -43,901 Closed
Barclays
30
Barclays
United Kingdom
– -$1.08M -42,673 Closed
PAM
31
Panagora Asset Management
Massachusetts
– -$928K -36,596 Closed
KPF
32
K2 Principal Fund
Ontario, Canada
– -$870K -34,275 Closed
AC
33
Athos Capital
Hong Kong
– -$865K -34,082 Closed
GH
34
GAM Holding
Switzerland
– -$700K -27,589 Closed
Morgan Stanley
35
Morgan Stanley
New York
– -$687K -27,088 Closed
HM
36
Harvest Management
New York
– -$685K -27,000 Closed
VEA
37
Virtus ETF Advisers
New York
– -$603K -23,777 Closed
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
– -$548K -21,615 Closed
GC
39
Guggenheim Capital
Illinois
– -$528K -20,823 Closed
KC
40
Kellner Capital
New York
– -$482K -19,000 Closed
HCMT
41
Highland Capital Management (Texas)
Texas
– -$318K -12,541 Closed
JP Morgan Chase
42
JP Morgan Chase
New York
– -$306K -12,066 Closed
Mitsubishi UFJ Asset Management
43
Mitsubishi UFJ Asset Management
Japan
– -$295K -11,629 Closed
SMC
44
S. Muoio & Co
New York
– -$254K -10,000 Closed
PCM
45
Prelude Capital Management
New York
– -$239K -9,410 Closed
Geode Capital Management
46
Geode Capital Management
Massachusetts
– -$209K -8,267 Closed
AG
47
Advisor Group
Arizona
– -$13K -500 Closed
CSS
48
Cubist Systematic Strategies
Connecticut
– -$7K -288 Closed
TRCT
49
Tower Research Capital (TRC)
New York
– -$6K -250 Closed
Bank of America
50
Bank of America
North Carolina
– -$5K -215 Closed
1
2
3

NITE Hedge Fund Activity: Q2 2019 in Review

0 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Nightstar Therapeutics plc American Depositary Shares (NITE) for Q2 2019, worth a combined $0 — down 100% from $279M a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of NITE and 0 opened new positions — a net loss of 53 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was TFG Asset Management, exiting entirely with an estimated $40.6M sold.

  • 0 institutional investors held Nightstar Therapeutics plc American Depositary Shares (NITE) as of Q2 2019, down from 53 in Q1 2019.
  • Funds reported $0 of Nightstar Therapeutics plc American Depositary Shares stock for Q2 2019, down 100% quarter-over-quarter.
  • 0 funds opened new Nightstar Therapeutics plc American Depositary Shares positions in Q2 2019 and 53 closed out, a net change of -53 holders.
  • The largest Nightstar Therapeutics plc American Depositary Shares seller in Q2 2019 was TFG Asset Management, an estimated $40.6M sold.

Based on aggregated 13F filings for Q2 2019.